Trials / Completed
CompletedNCT00933621
Intracoronary Injection of Autologous Bone Marrow Cells in Patients With Chronic Heart Failure: Five Years Follow up
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Assaf-Harofeh Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 88 Years
- Healthy volunteers
- Not accepted
Summary
The study aim is to evaluate the long term outcome of intra-coronary autologous bone marrow (BM) transplantation in patients with severe ischemic cardiomyopathy without the option for revascularization.
Detailed description
Several studies have demonstrated the short term safety, feasibility and efficacy of cell transplantation in patients with advanced heart failure. There are no data about the long term outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Autologous bone marrow intracoronary infusion | Percutaneous intracoronary mononuclear bone marrow cell infusion |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2003-05-01
- Completion
- 2003-12-01
- First posted
- 2009-07-07
- Last updated
- 2009-07-07
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00933621. Inclusion in this directory is not an endorsement.